✦ LIBER ✦

Evaluation of Sustained/Controlled-Release Dosage Forms of 3-Hydroxy-3-methylglutaryl–Coenzyme A (HMG-CoA) Reductase Inhibitors in Dogs and Humans

✍ Scribed by Haiyung Cheng; Steven C. Sutton; James D. Pipkin; Gaylen M. Zentner; J. Douglas Rogers; Jules I. Schwartz; Yale B. Mitchel; Kenneth Grasing; Michael S. Schwartz; Raju D. Amin; Lida Liu; David L. Ebel; Amy Coulter; Karen Engle; Gregory A. McClelland; Chung Y. Lui; Gerald S. Rork

Book ID: 110380696
Publisher: Springer US
Year: 1993
Tongue: English
Weight: 844 KB
Volume: 10
Category: Article
ISSN: 0724-8741
DOI: 10.1023/a:1018997308946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancement of 3-Hydroxy-3-methylglutary

Enhancement of 3-Hydroxy-3-methylglutaryl–Coenzyme A (HMG–CoA) Reductase Inhibitor Efficacy Through Administration of a Controlled-Porosity Osmotic Pump Dosage Form

✍ Gregory A. McClelland; R. John Stubbs; Joseph A. Fix; Stefano A. Pogany; Gaylen 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 609 KB

Comparison of 3-Hydroxy-3-methylglutaryl

Comparison of 3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors (Statins) as Inhibitors of Cytochrome P450 2C8

✍ Aleksi Tornio; Marja K. Pasanen; Jouko Laitila; Pertti J. Neuvonen; Janne T. Bac 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Comparing myotoxic effects of squalene s

Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes

✍ Tomoyuki Nishimoto; Ryuichi Tozawa; Yuichiro Amano; Takeo Wada; Yoshimi Imura; Y 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Hypocholesterolemic effects of 3-hydroxy

Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: Atorvastatin versus simvastatin

✍ Karin Conde; Graciela Pineda; Roger S Newton; Maria Luz Fernandez 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 405 KB

The isolation, characterisation, and chr

The isolation, characterisation, and chromosomal assignment of the gene for human 3-hydroxy-3-methylglutaryl coenzyme A reductase, (HMG-CoA reductase)

✍ S. E. Humphries; F. Tata; I. Henry; F. Barichard; M. Holm; C. Junien; R. William 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 476 KB

We have used a cDNA clone for Chinese hamster 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase to isolate a genomic recombinant for human HMG-CoA reductase. The identity of the gene was confirmed by partial sequence analysis. Several unique fragments that will be useful for restriction frag

Relative lipophilicities, solubilities,

Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-COA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin

✍ Abu T. M. Serajuddin; Sunanda A. Ranadive; Eileen M. Mahoney 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

The apparent octanol-water partition coefficients (Po/w) and aqueous solubilities for four 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors [pravastatin, lovastatin (mevinolin), mevastatin (compactin), and simvastatin (synvinolin)] were compared. Pravastatin is highly hydrophilic